GlassScriptPhysician profile
Alejandro J Correa
NPI 1154364370
$1,072.32
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $130 · 2021: $249 · 2022: $149 · 2023: $36.23 · 2024: $99.55 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.05 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $394.83 | 2019-2024 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Depuy Synthes Sales INC. | $254.33 | 2021-2025 | Trumatch |
| Regeneron Healthcare Solutions, INC. | $142.11 | 2019-2025 | Dupixent, Libtayo |
| Stryker Corporation | $105.07 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $41.48 | 2019 | |
| Amgen INC. | $34.00 | 2025 | |
| Hikma Pharmaceuticals USA | $27.42 | 2023-2025 | Ryaltris |
| Organogenesis INC. | $24.27 | 2022 | |
| Hologic Sales and Service, LLC | $22.64 | 2022 | |
| Axogen | $13.40 | 2019 | |
| Optinose US, INC. | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alejandro Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.